Table 1.
Blood concentrations of MA in 506 deaths involving MA
| Group A1 | Group A2 | Group B | Group C | Group D | |
|---|---|---|---|---|---|
| Median, IQR | Median, IQR | Median, IQR | Median, IQR | ||
| n | 1 | 8 | 28 | 229 | 240 |
| MA concentration | 2.1 | 1.6, 0.7–1.9a | 0.5, 0.22–1.6a | 0.2, 0.088–0.44b | 0.2, 0.074–0.44b |
| Amphetamine concentration | 0.37 | 0.14, 0.068–0.19a, b | 0.1, 0.041–0.29a | 0.062, 0.032–0.011a, c | 0.049, 0.03–0.083b, c |
| Sum concentrationd | 2.4 | 1.7, 0.79–2.2a | 0.64, 0.26–1.9a | 0.26, 0.11–0.52b | 0.24, 0.079–0.5b |
| Ratioe | 0.18 | 0.11, 0.077–0.14a | 0.12, 0.088–0.22a | 0.20, 0.13–0.36b | 0.17, 0.11–0.29a, b |
Different letters within rows denote statistically significant differences between respective groups in median values by Dunn’s procedure using Bonferroni correction for multiple tests, excluding Group A1 (refer to Table S2 for Kruskal–Wallis H test statistics and the adjusted p-values of the Dunn’s procedure pairwise comparison test)
Concentrations are in mg/L
MA methylamphetamine, IQR inter-quartile range
dSum concentration of MA and amphetamine
eAmphetamine:MA concentration ratio